A political novice and one of the world’s wealthiest millennials, Vivek Ramaswamy has waged a whirlwind presidential campaign mirroring his meteoric rise as a biotech entrepreneur. On everything from deporting people born in the United States to ending aid to Israel and Ukraine, he consistently displays the bravado of a populist, self-declared outsider.
“I stand on the side of revolution,” he declares. “That’s what I’m going to lead in a way that no establishment politician can.”
In business and politics, though, Ramaswamy has run into skeptics and sometimes hard facts that threatened to derail his ambitions. In the 2024 campaign, the Israel-Hamas war has refocused the Republican primary on foreign policy and exposed just how much Ramaswamy’s self-declared revolutionary approach puts him at odds with the party’s most powerful figures and many of its voters.
This is the best summary I could come up with:
ATLANTA (AP) — A political novice and one of the world’s wealthiest millennials, Vivek Ramaswamy has waged a whirlwind presidential campaign mirroring his meteoric rise as a biotech entrepreneur.
In the 2024 campaign, the Israel-Hamas war has refocused the Republican primary on foreign policy and exposed just how much Ramaswamy’s self-declared revolutionary approach puts him at odds with the party’s most powerful figures and many of its voters.
He interned at Goldman Sachs, the most prestigious Wall Street investment house, then won a job at QVT Financial, founded by another Harvard alumnus, Dan Gold.
He named it Roivant — the ROI standing for “return on investment” — and had a clear business model in mind: Buy discount patents for drugs languishing in the development phase, then resurrect them.
In his first big move, Ramaswamy used a subsidiary, Axovant, and paid GlaxoSmithKline $5 million for RVT-101, a potential Alzheimer’s drug already put through multiple trials and deemed not promising enough to continue.
Yet Trump remains such an overwhelming favorite to win the GOP nomination that he has skipped each debate, leaving Ramaswamy to absorb punches most candidates never direct toward the former president.
The original article contains 1,407 words, the summary contains 192 words. Saved 86%. I’m a bot and I’m open source!
So wait, this genius businessman thinks he can make money buying parents for drugs even the large pharmaceutical companies didn’t find worth pursuing?
How could that possibly turn out to be a solvent business model?